X4 Pharmaceuticals XFOR Peer Comparison

NASDAQ XFOR
$4.04 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT
Peer Comparison

221 Comparable Companies

Industry Pharmaceuticals

X4 Pharmaceuticals, Inc (XFOR) is the 107th largest of 221 Pharmaceuticals companies by market capitalisation, at 510.43 Mn, behind Adlai Nortye Ltd. at 515.40 Mn. The table below compares all 221 on 8 financial metrics.

Download Data
# Ticker Company match industry_code industry_group industry_group_code Market Capitalization P/E P/S Enterprise Value
1 JNJ Johnson & Johnson primary H-01 Pharmaceuticals and Biotechnology HG-01 663.08 Bn 31.49 6.77 642.33 Bn
2 ABBV AbbVie Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 453.04 Bn 71.80 7.04 446.51 Bn
3 MRK Merck & Co., Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 370.87 Bn 117.16 5.57 363.78 Bn
4 NVS Novartis Ag primary H-01 Pharmaceuticals and Biotechnology HG-01 305.29 Bn 13.79 4.44 298.00 Bn
5 PFE Pfizer Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 162.10 Bn 37.11 2.54 150.70 Bn
6 SNY Sanofi primary H-01 Pharmaceuticals and Biotechnology HG-01 53.95 Bn 11.58 1.01 46.98 Bn
7 RVMD Revolution Medicines, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 45.00 Bn -25.05 — 45.00 Bn
8 ONC BeOne Medicines Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 40.49 Bn 60.96 6.61 35.39 Bn
9 INCY Incyte Corp primary H-01 Pharmaceuticals and Biotechnology HG-01 25.47 Bn 15.75 4.38 20.94 Bn
10 UTHR UNITED THERAPEUTICS Corp primary H-01 Pharmaceuticals and Biotechnology HG-01 20.81 Bn 15.85 6.60 18.15 Bn
11 JAZZ Jazz Pharmaceuticals plc primary H-01 Pharmaceuticals and Biotechnology HG-01 16.02 Bn 16.58 3.48 14.40 Bn
12 NBIX Neurocrine Biosciences Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 15.81 Bn 22.28 4.69 15.42 Bn
13 EXEL Exelixis, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 14.69 Bn 17.20 6.03 13.85 Bn
14 CORT Corcept Therapeutics Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 12.07 Bn 217.01 14.52 11.76 Bn
15 AXSM Axsome Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 10.81 Bn -69.64 13.92 10.49 Bn
16 GPCR Structure Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 10.11 Bn -54.84 — 10.11 Bn
17 CYTK Cytokinetics Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 10.11 Bn -13.09 149.40 8.94 Bn
18 NUVL Nuvalent, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 9.75 Bn -27.07 — 9.75 Bn
19 KYMR Kymera Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 9.72 Bn -38.47 92.56 9.03 Bn
20 CRNX Crinetics Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 8.99 Bn -17.90 213.22 8.99 Bn
21 ALKS Alkermes plc. primary H-01 Pharmaceuticals and Biotechnology HG-01 7.72 Bn 116.43 4.63 7.07 Bn
22 BLTE Belite Bio, Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 7.62 Bn -84.28 — 7.62 Bn
23 TVTX Travere Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 6.15 Bn -140.40 10.40 6.03 Bn
24 LQDA Liquidia Corp primary H-01 Pharmaceuticals and Biotechnology HG-01 6.12 Bn 44.04 13.57 5.83 Bn
25 AMRN Amarin Corp Plc\Uk primary H-01 Pharmaceuticals and Biotechnology HG-01 5.73 Bn -209.27 30.74 5.41 Bn
26 ACAD Acadia Pharmaceuticals Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 4.82 Bn 12.64 4.24 3.87 Bn
27 EWTX Edgewise Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 4.64 Bn -23.51 — 4.64 Bn
28 ELVN Enliven Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 4.35 Bn -46.65 — 4.35 Bn
29 DFTX Definium Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 4.22 Bn -11.92 — 4.22 Bn
30 INDV Indivior Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 4.12 Bn 11.71 3.10 3.90 Bn
31 MANE Veradermics, Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 4.11 Bn -46.17 — 4.11 Bn
32 TARS Tarsus Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 3.93 Bn -83.93 6.48 3.48 Bn
33 CPRX CATALYST PHARMACEUTICALS, INC. primary H-01 Pharmaceuticals and Biotechnology HG-01 3.85 Bn 17.94 6.45 3.09 Bn
34 OGN Organon & Co. primary H-01 Pharmaceuticals and Biotechnology HG-01 3.62 Bn 17.31 0.59 2.49 Bn
35 NAMS NewAmsterdam Pharma Co N.V. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.99 Bn -12.08 419.65 2.99 Bn
36 TAK Takeda Pharmaceutical Co Ltd primary H-01 Pharmaceuticals and Biotechnology HG-01 2.67 Bn 4.61 0.06 -3.12 Bn
37 SUPN Supernus Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.53 Bn -29.70 3.21 2.16 Bn
38 MLYS Mineralys Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.49 Bn -6.84 — 2.49 Bn
39 TRVI Trevi Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.46 Bn -64.08 — 2.46 Bn
40 HRMY Harmony Biosciences Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.46 Bn 13.72 2.56 1.65 Bn
41 NUVB Nuvation Bio Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.36 Bn -21.96 13.89 2.36 Bn
42 PVLA Palvella Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.26 Bn -42.59 — 1.95 Bn
43 AUPH Aurinia Pharmaceuticals Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.14 Bn 6.66 6.86 1.69 Bn
44 ETON Eton Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.65 Bn 169.20 16.49 1.63 Bn
45 INVA Innoviva, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.55 Bn 7.98 3.01 0.97 Bn
46 XERS Xeris Biopharma Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.48 Bn -85.88 4.41 1.36 Bn
47 HROW Harrow, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.44 Bn -43.03 5.24 1.36 Bn
48 LBRX Lb Pharmaceuticals Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 1.42 Bn -24.58 — 1.42 Bn
49 OPK Opko Health, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.22 Bn -32.69 2.08 0.92 Bn
50 KURA Kura Oncology, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.18 Bn -4.95 15.26 1.18 Bn
51 PCRX Pacira BioSciences, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.05 Bn 71.04 1.41 0.80 Bn
52 LXRX Lexicon Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.00 Bn -15.59 24.14 0.81 Bn
53 SGP SpyGlass Pharma, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.97 Bn -48.72 — 0.97 Bn
54 DSGN Design Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.95 Bn -11.70 — 0.74 Bn
55 OLMA Olema Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.94 Bn -5.50 — 0.94 Bn
56 IVA Inventiva S.A. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.92 Bn 9.58 177.00 0.92 Bn
57 COLL Collegium Pharmaceutical, Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.76 Bn 15.94 0.95 0.62 Bn
58 PHAT Phathom Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.76 Bn -8.10 3.17 0.58 Bn
59 VSTM Verastem, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.74 Bn -7.12 8.48 0.61 Bn
60 ZVRA Zevra Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.74 Bn 12.59 5.40 0.51 Bn
61 GYRE Gyre Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.73 Bn -37.38 6.09 0.70 Bn
62 AQST Aquestive Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.67 Bn -8.53 12.39 0.57 Bn
63 CRMD CorMedix Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.65 Bn 5.25 1.75 0.40 Bn
64 NVCT Nuvectis Pharma, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.65 Bn -18.99 — 0.65 Bn
65 MPLT MapLight Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.63 Bn -3.10 — 0.63 Bn
66 EOLS Evolus, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.61 Bn -17.86 1.94 0.57 Bn
67 SPRY ARS Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.56 Bn -2.52 4.78 0.41 Bn
68 OVID Ovid Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.52 Bn -16.03 326.79 0.40 Bn
69 XFOR X4 Pharmaceuticals, Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.51 Bn -5.66 32.21 0.32 Bn
70 IKT Inhibikase Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -6.67 — 0.38 Bn
71 VTVT vTv Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.41 Bn -87.02 11.23 0.41 Bn
72 ACHV Achieve Life Sciences, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.37 Bn — — 0.37 Bn
73 PALI Palisade Bio, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.36 Bn -12.52 725.63 0.24 Bn
74 VNDA Vanda Pharmaceuticals Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.33 Bn -1.19 1.52 0.16 Bn
75 SION Sionna Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -3.33 — 0.32 Bn
76 EBS Emergent BioSolutions Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -1.81 0.41 0.18 Bn
77 IMRX Immuneering Corp primary H-01 Pharmaceuticals and Biotechnology HG-01 0.31 Bn -5.31 — 0.31 Bn
78 FULC Fulcrum Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.29 Bn -3.30 — 0.29 Bn
79 TTRX Turn Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.29 Bn -37.91 — 0.29 Bn
80 CELG-RI Bristol Myers Squibb Co primary H-01 Pharmaceuticals and Biotechnology HG-01 0.29 Bn 0.03 0.01 -10.78 Bn
81 ZNTL Zentalis Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.29 Bn -2.04 — 0.29 Bn
82 AKBA Akebia Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -8.82 1.20 0.11 Bn
83 SIGA Siga Technologies Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.24 Bn — — 0.08 Bn
84 TNXP Tonix Pharmaceuticals Holding Corp. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -1.37 7.58 0.22 Bn
85 CRDL Cardiol Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -7.36 — 0.22 Bn
86 DERM Journey Medical Corp primary H-01 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -59.11 3.17 0.19 Bn
87 NERV Minerva Neurosciences, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -31.43 — 0.21 Bn
88 ACOG Alpha Cognition Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -7.55 15.49 0.17 Bn
89 SLGL Sol-Gel Technologies Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -18.47 107.91 0.15 Bn
90 MCUJF Medicure Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -35.91 8.18 0.19 Bn
91 LENZ LENZ Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -1.45 8.72 0.19 Bn
92 MENS Jyong Biotech Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -46.69 — 0.18 Bn
93 LONA LeonaBio, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -1.47 — 0.13 Bn
94 BMEA Biomea Fusion, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -2.60 — 0.15 Bn
95 VANI Vivani Medical, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -4.77 — 0.11 Bn
96 NTHI Neonc Technologies Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -2.79 — 0.13 Bn
97 AARD Aardvark Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.12 Bn -1.68 — 0.04 Bn
98 CPIX Cumberland Pharmaceuticals Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -9.44 3.25 0.10 Bn
99 CGTX Cognition Therapeutics Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -2.55 — 0.10 Bn
100 VRCA Verrica Pharmaceuticals Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -3.59 3.00 0.08 Bn
101 RGC Regencell Bioscience Holdings Ltd primary H-01 Pharmaceuticals and Biotechnology HG-01 0.09 Bn — — 0.09 Bn
102 PTHS Pelthos Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -0.76 1.66 0.06 Bn
103 TENX Tenax Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -1.35 — 0.09 Bn
104 MNOV Medicinova Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -6.98 91.85 0.08 Bn
105 PLRX Pliant Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -0.78 — 0.07 Bn
106 CING Cingulate Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -3.11 — 0.07 Bn
107 PMVP PMV Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -1.14 — -0.01 Bn
108 BOLD Boundless Bio, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -1.01 — 0.06 Bn
109 VERU Veru Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.06 Bn 121.51 — 0.04 Bn
110 ANVS Annovis Bio, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -1.06 — 0.06 Bn
111 GOSS Gossamer Bio, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -0.34 1.08 0.00 Bn
112 KPTI Karyopharm Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.26 0.35 -0.01 Bn
113 CLNN Clene Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -1.43 235.39 0.05 Bn
114 IXHL Incannex Healthcare Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.83 — 0.04 Bn
115 APRE Aprea Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -3.39 — 0.04 Bn
116 SCLX Scilex Holding Co primary H-01 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.08 1.20 -0.08 Bn
117 ACTU Actuate Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.70 — 0.04 Bn
118 GRCE Grace Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -1.82 — 0.03 Bn
119 NSRX Nasus Pharma Ltd primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -5.64 — 0.03 Bn
120 CPHI China Pharma Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -7.43 8.49 0.03 Bn
121 UG United Guardian Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 14.50 2.93 0.02 Bn
122 CRVO CervoMed Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -0.86 79.16 0.03 Bn
123 YARW Yarrow Bioscience, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -1.24 51.63 0.00 Bn
124 TXMD TherapeuticsMD, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -138.26 7.82 0.02 Bn
125 BYSI BeyondSpring Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -3.02 — 0.03 Bn
126 ATOS Atossa Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -0.74 — 0.03 Bn
127 AYTU Aytu Biopharma, Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.76 0.42 0.00 Bn
128 BFRI Biofrontera Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -4.42 0.51 0.02 Bn
129 ALLR Allarity Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.87 903.73 0.02 Bn
130 MIRA Mira Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.54 — 0.01 Bn
131 TVRD Tvardi Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.68 — 0.02 Bn
132 CTXR Citius Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.33 2.28 0.03 Bn
133 ANEB Anebulo Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.78 — 0.02 Bn
134 KPRX Kiora Pharmaceuticals Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.43 — 0.02 Bn
135 INTI Inhibitor Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -4.72 — 0.02 Bn
136 CALC CalciMedica, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.35 -8.79 -0.01 Bn
137 CURX Curanex Pharmaceuticals Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.97 — 0.00 Bn
138 RVPH Reviva Pharmaceuticals Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.78 — 0.01 Bn
139 ACXP Acurx Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.81 — 0.01 Bn
140 PCSA Processa Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.42 — 0.01 Bn
141 TRAW Traws Pharma, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.35 — 0.00 Bn
142 PULM Pulmatrix, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -1.25 — 0.01 Bn
143 TCRT Alaunos Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.98 1,350.80 0.00 Bn
144 CVKD Cadrenal Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.30 — 0.00 Bn
145 BICX BioCorRx Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -1.64 6.70 0.00 Bn
146 ADXN Addex Therapeutics Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn 0.05 — 0.00 Bn
147 CASIF CASI Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.02 0.12 0.00 Bn
148 OGEN Oragenics Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.23 — 0.00 Bn
149 SKVI Skinvisible, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -2.25 116.18 0.00 Bn
150 CANF Can-Fite BioPharma Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.19 4.57 -0.01 Bn
151 UPC Universe Pharmaceuticals INC primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn — — -1,490.23 Bn
152 JAGX Jaguar Health, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.01 0.05 -0.01 Bn
153 ENSC Ensysce Biosciences, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn — — 0.00 Bn
154 MTNB Matinas BioPharma Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.16 — 0.00 Bn
155 SPRC SciSparc Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.05 0.76 0.00 Bn
156 NCEL NewcelX Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.06 — 0.00 Bn
157 GLMD Galmed Pharmaceuticals Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn — — 0.00 Bn
158 CDT CDT Equity Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.01 — 0.00 Bn
159 GCAN Trafalgar International, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -1.77 — 0.00 Bn
160 SXTC China SXT Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn 0.00 0.03 -0.03 Bn
161 CMND Clearmind Medicine Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn 0.00 — -0.01 Bn
162 GILD Gilead Sciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 187.38 Bn -64.83 6.15 184.12 Bn
163 VRTX Vertex Pharmaceuticals Inc / Ma secondary H-02 Pharmaceuticals and Biotechnology HG-01 138.36 Bn 31.45 10.99 130.51 Bn
164 TEVA Teva Pharmaceutical Industries Ltd secondary H-04 Pharmaceuticals and Biotechnology HG-01 42.34 Bn 60.81 2.45 38.68 Bn
165 ALC Alcon Inc secondary H-06 Medical Devices and Diagnostics HG-02 34.36 Bn 29.19 3.19 32.91 Bn
166 GEHC GE HealthCare Technologies Inc. secondary H-08 Medical Devices and Diagnostics HG-02 31.10 Bn 15.21 1.46 29.22 Bn
167 INSM INSMED Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 27.57 Bn -31.36 24.23 26.41 Bn
168 ROIV Roivant Sciences Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 25.24 Bn -16.96 2,310.98 25.93 Bn
169 VTRS Viatris Inc secondary H-04 Pharmaceuticals and Biotechnology HG-01 19.39 Bn -47.81 1.32 18.50 Bn
170 BWXT BWX Technologies, Inc. secondary I-39 Clean Energy Equipment IG-10 14.44 Bn 40.58 4.11 13.83 Bn
171 GKOS GLAUKOS Corp secondary H-06 Medical Devices and Diagnostics HG-02 10.46 Bn -66.34 17.06 10.34 Bn
172 PRAX Praxis Precision Medicines, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.82 Bn -26.87 — 9.06 Bn
173 BLRX BioLineRx Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.97 Bn -734.96 5,007.81 6.97 Bn
174 BLCO Bausch & Lomb Corp secondary H-06 Medical Devices and Diagnostics HG-02 6.45 Bn -39.59 1.21 6.14 Bn
175 AMRX Amneal Pharmaceuticals, Inc. secondary H-04 Pharmaceuticals and Biotechnology HG-01 5.57 Bn 25.85 1.79 5.53 Bn
176 ERAS Erasca, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.06 Bn -17.55 — 5.06 Bn
177 RCUS Arcus Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.77 Bn -8.13 32.18 3.06 Bn
178 DNLI Denali Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.56 Bn -8.16 987.61 3.56 Bn
179 IMNM Immunome Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.03 Bn -11.21 593.06 2.51 Bn
180 ZLAB Zai Lab Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.94 Bn -15.57 6.55 2.24 Bn
181 SLS SELLAS Life Sciences Group, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.80 Bn -80.78 — 2.80 Bn
182 NRIX Nurix Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.71 Bn -8.51 73.73 2.27 Bn
183 CURLF Curaleaf Holdings, Inc. secondary S-09 Tobacco and Cannabis SG-04 2.61 Bn -21.89 2.00 2.52 Bn
184 BCRX Biocryst Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.54 Bn -6.59 4.75 2.19 Bn
185 BHC Bausch Health Companies Inc. secondary H-04 Pharmaceuticals and Biotechnology HG-01 2.45 Bn -2.25 0.23 1.58 Bn
186 BHVN Biohaven Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.37 Bn -4.03 — 2.10 Bn
187 FMS Fresenius Medical Care AG secondary H-14 Healthcare Providers HG-04 2.11 Bn 1.84 0.08 1.41 Bn
188 ZBIO Zenas BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.08 Bn -4.99 2,082.32 2.08 Bn
189 ANIP Ani Pharmaceuticals Inc secondary H-04 Pharmaceuticals and Biotechnology HG-01 1.70 Bn 13.96 1.74 1.34 Bn
190 AAPG Ascentage Pharma Group International secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.66 Bn -9.11 20.12 1.38 Bn
191 RARE Ultragenyx Pharmaceutical Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.51 Bn -3.37 2.10 1.22 Bn
192 AVBP ArriVent BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.50 Bn -9.00 — 1.50 Bn
193 OMER Omeros Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.37 Bn 80.09 35.55 1.37 Bn
194 CRVS Corvus Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.21 Bn -27.82 — 1.00 Bn
195 MNPR Monopar Therapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.00 Bn -72.45 — 0.95 Bn
196 ACRS Aclaris Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.86 Bn -11.07 104.97 0.86 Bn
197 OCS Oculis Holding AG secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.64 Bn -362,547.56 — 0.64 Bn
198 DCTH Delcath Systems, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.57 Bn 1,197.37 5.98 0.47 Bn
199 ANL Adlai Nortye Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.52 Bn -10.27 78.36 0.28 Bn
200 EVMN Evommune, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn -4.68 44.52 0.24 Bn
201 PRLD Prelude Therapeutics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -7.97 19.43 0.16 Bn
202 IRD Opus Genetics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.39 Bn -4.59 39.16 0.30 Bn
203 SWKHL SWK Holdings Corp secondary F-06 Lending and Credit FG-02 0.31 Bn -332.24 7.43 0.27 Bn
204 FTH Faeth Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -1.16 — 0.23 Bn
205 IFRX InflaRx N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -3.70 2,035.87 -0.02 Bn
206 SPRB Spruce Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -2.91 — 0.16 Bn
207 TNYA Tenaya Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -1.43 114.21 0.15 Bn
208 PYPD PolyPid Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn 2.80 — 0.09 Bn
209 FBIO Fortress Biotech, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 10.35 1.32 -0.06 Bn
210 AIFC AI Financial Corp secondary T-54 Fintech TG-09 0.08 Bn -0.09 3.90 0.08 Bn
211 PTN Palatin Technologies Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -7.93 3.86 0.05 Bn
212 APLM Apollomics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -3.72 4.79 0.04 Bn
213 KAPA Kairos Pharma, LTD. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -6.19 0.38 0.03 Bn
214 BETRF BetterLife Pharma Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -21.82 — 0.04 Bn
215 MDBH MDB Capital Holdings, LLC secondary F-17 Capital Markets FG-05 0.03 Bn -1.29 — 0.02 Bn
216 RKTO Rocket One Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.08 — 0.01 Bn
217 QCLS Q/C Technologies, Inc. secondary T-01 Semiconductors TG-01 0.01 Bn -2.05 — 0.02 Bn
218 TPST Tempest Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.28 — 0.00 Bn
219 INM InMed Pharmaceuticals Inc. secondary M-02 Chemicals MG-01 0.00 Bn -0.70 — 0.00 Bn
220 BTAI BioXcel Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.03 2.95 0.00 Bn
221 ZCMD Zhongchao Inc. secondary T-27 Vertical Software TG-05 0.00 Bn -0.01 0.00 -0.01 Bn